BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Phoenix Bioscience Core - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://phoenixbiosciencecore.com
X-WR-CALDESC:Events for Phoenix Bioscience Core
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Phoenix:20230314T120000
DTEND;TZID=America/Phoenix:20230314T130000
DTSTAMP:20230223T221305Z
CREATED:20230223T221305Z
LAST-MODIFIED:20230223T221305Z
UID:3466-1678795200-1678798800@phoenixbiosciencecore.com
SUMMARY:Is Your Life Sciences Patent Enabled? U.S. Supreme Court Will Decide This Year
DESCRIPTION:In this year’s foray into patent law\, the Supreme Court will decide whether Amgen’s patent that claims antibodies by functional antigen binding and does not disclose the full range of antibody sequences is invalid for not meeting the enablement requirements of Section 112(b). \nJoin us for this webinar on Tuesday\, March 14 where Procopio experts in patent prosecution and patent litigation will discuss the background of the case and how the Supreme Court’s decision may impact the ability to obtain certain life science\, chemical and pharma patents and how it may provide additional ammunition to attack such patents in patent litigation. \nLearn more and register here.
URL:https://phoenixbiosciencecore.com/event/is-your-life-sciences-patent-enabled-u-s-supreme-court-will-decide-this-year/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR